Dopamine transporter development in postnatal rat striatum: An autoradiographic study with [3H]WIN 35,428

Developmental Brain Research

Volumn 104, Issue 1-2, 1997, Pages 55-62

  Coulter, Cynthia L ^a   Happe, H Kevin ^b   Murrin, L Charles ^b  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Autoradiography; Caudate putamen; Cocaine receptor; Development; Dopamine transporter; WIN 35,248

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; COCAINE; DOPAMINE TRANSPORTER;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; DRUG DEPENDENCE; LIGAND BINDING; NEWBORN; NONHUMAN; POSTNATAL DEVELOPMENT; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROTEIN MODIFICATION; RAT; REINFORCEMENT; TISSUE DISTRIBUTION;

ANIMALS; AUTORADIOGRAPHY; CARRIER PROTEINS; COCAINE; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; TRITIUM;

ANIMALIA;

EID: 0031578730     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(97)00135-1     Document Type: Article

References (46)

1. [1] D.B. Bylund, Analysis of receptor binding data, in: D.B. Bylund (Ed.), Receptor Binding Techniques, Society for Neuroscience, Bethesda, MD, 1980, pp. 70-99.
2. [2] F.I. Carroll, P. Abraham, A.M. Lewin, K.A. Parham, J.W. Boja, M.J. Kuhar, Isopropyl and phenyl esters of 3β-(4-substituted phenyl)tropan-2β-carboxylic acids. Potent and selective compounds for the dopamine transporter, J. Med. Chem. 35 (1992) 2497-2500.
3. [3] B.J. Ciliax, C. Heilman, L.L. Demchyshyn, Z.B. Pristupa, E. Ince, S.M. Hersch, H.B. Niznik, A.I. Levey, The dopamine transporter: immunochemical characterization and localization in brain, J. Neurosci. 15 (1995) 1714-1723.
4. [4] E.H. Cook Jr., M.A. Stein, M.D. Krasowski, N.J. Cox, D.M. Olkon, J.E. Kieffer, B.L. Leventhal, Association of attention-deficit disorder and the dopamine transporter gene, Am. J. Hum. Genet. 56 (1995) 993-998.
5. 125I]RTI-55, Brain Res. 690 (1995) 217-224.
6. 3H]WIN 35, 428, Soc. Neurosci. Abstr. 19 (1993) 1093.
7. [7] C.L. Coulter, H.K. Happe, L.C. Murrin, Postnatal development of the dopamine transporter: a quantitative autoradiographic study, Dev. Brain Res. 92 (1996) 172-181.
8. [8] J.T. Coyle, P. Campochiaro, Ontogenesis of dopaminergic-cholinergic interactions in the rat striatum: a neurochemical study, J. Neurochem. 27 (1976) 673-678.
9. [9] C. Freed, R. Revay, R.A. Vaughan, E. Kriek, S. Grant, G.R. Uhl, M.J. Kuhar, Dopamine transporter immunoreactivity in rat brain, J. Comp. Neurol. 359 (1995) 340-349.
10. [10] B. Giros, M. Jamber, S.R. Jones, R.M. Wightman, M.G. Caron, Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter, Nature 379 (1996) 606-612.
11. 3H]CFT) binds to multiple charge-states of the solubilized dopamine transporter in primate striatum, J. Pharmacol. Exp. Ther. 273 (1995) 1224-1234.
12. [12] D.R. Griffith, S.D. Azuma, I.J. Chasnoff, Three-year outcome of children exposed prenatally to drugs, J. Am. Acad. Child Adolesc. Psychiatry 33 (1994) 20-27.
13. [13] H.K. Happe, L.C. Murrin, Tritium quench in autoradiography during postnatal development of rat forebrain, Brain Res. 525 (1990) 28-35.
14. max, J. Neurochem. 68 (1997) 225-232.
15. [15] L.L. Iversen, Role of transmitter uptake mechanisms in synaptic neurotransmission, Br. J. Pharmacol. 41 (1971) 571-591.
16. [16] S. Kitayama, T. Dohi, G.R. Uhl, Phorbol esters alter functions of the expressed dopamine transporter, Eur. J. Pharmacol. - Mol. Pharmacol. 268 (1994) 115-119.
17. [17] I.J. Kopin, S.P. Markey, MPTP toxicity: implications for research in Parkinson's Disease, Annu. Rev. Neurosci. 11 (1988) 81-96.
18. 3H]cyanoimipramine, Brain Res. 454 (1988) 78-88.
19. [19] M.J. Kuhar, M.C. Ritz, J.W. Boja, The dopamine hypothesis of the reinforcing properties of cocaine, Trends Neurosci. 14 (1991) 299-302.
20. 3H]-GBR12935 to measure dopaminergic nerve terminal growth into the developing striatum, Dev. Brain Res. 67 (1992) 375-377.
21. [21] C.A. Leslie, M.W. Robertson, A.B. Jung, J. Liebermann, J.P. Bennett Jr., Effects of prenatal cocaine exposure upon postnatal development of neostriatal dopaminergic function, Synapse 17 (1994) 210-215.
22. [22] R. Lew, A. Patel, R.A. Vaughan, A. Wilson, M.J. Kuhar, Microheterogeneity of dopamine transporters in rat striatum and nucleus accumbens, Brain Res. 584 (1992) 266-271.
23. [23] L.A. Loizou, The postnatal ontogeny of monoamine-containing neurones in the central nervous system of the albino rat, Brain Res. 40 (1972) 396-418.
24. [24] L.C. Mayes, R.H. Granger, M.A. Frank, R. Schottenfeld, M.H. Bornstein, Neurobehavioral profiles of neonates exposed to cocaine prenatally, Pediatrics 91 (1993) 778-783.
25. [25] L.C. Murrin, In vivo studies of dopamine receptor ontogeny, Life Sci. 31 (1982) 971-980.
26. [26] L.C. Murrin, J.R. Ferrer, Ontogeny of the striatum: correspondence of dopamine terminals, opiate receptors and acetylcholinesterase, Neurosci. Lett. 47 (1984) 155-160.
27. [27] L.C. Murrin, D. Gibbens, J.R. Ferrer, Ontogeny of dopamine, serotonin and spirodecanone receptors in rat forebrain: an autoradiographic study, Dev. Brain Res. 23 (1985) 91-109.
28. [28] L.C. Murrin, H.K. Happe, C.L. Coulter, D.A. Bergman, Dopamine transporter affinity for ligands changes significantly with tissue preparation, Soc. Neurosci. Abstr. 21 (1995) 376.
29. 1 receptor development in the rat striatum: early localization in striosomes, Brain Res. 480 (1989) 170-177.
30. 3H]GBR-12935 binding proteins, Arch. Biochem. Biophys. 276 (1990) 424-432.
31. [31] L. Olson, A. Seiger, K. Fuxe, Heterogeneity of striatal and limbic dopamine innervation: highly fluorescent islands in developing and adult rats, Brain Res. 44 (1972) 283-288.
32. [32] A.P. Patel, C. Cerruti, R.A. Vaughan, M.J. Kuhar, Developmentally regulated glycosylation of dopamine transporter, Dev. Brain Res. 83 (1994) 53-58.
33. [33] G. Paxinos and C. Watson, The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, Sydney, 1986, 237 pp.
34. 3H]GBR 12,935 binding, Mol. Pharmacol. 45 (1994) 125-135.
35. 2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study, Dev. Brain Res. 60 (1991) 161-177.
36. 3H]cocaine binding sites, Naunyn-Schmiedeberg's Arch. Pharmacol. 351 (1995) 136-145.
37. 3H]WIN 35,428) binding, Biochem. Pharmacol. 52 (1996) 1435-1446.
38. 3H]GBR 12935: binding characteristics, Brain Res. 540 (1991) 1-13.
39. [39] S. Saadouni, F. Refahi-Lyamani, J. Costentin, J.-J. Bonnet, Cocaine and GBR 12783 recognize nonidentical, overlapping binding domains on the dopamine neuronal carrier, Eur. J. Pharmacol. - Mol. Pharmacol. 268 (1994) 187-197.
40. [40] H.S. Singer, I.-H. Hahn, T.H. Moran, Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's Syndrome, Ann. Neurol. 30 (1991) 558-562.
41. [41] L. Singer, R. Arendt, L.Y. Song, E. Warshawsky, R. Kliegman, Direct and indirect interactions of cocaine with childbirth outcomes, Arch. Pediatr. Adolesc. Med. 148 (1994) 959-964.
42. [42] R.A. Vaughan, R.A. Huff, G.R. Uhl, M.J. Kuhar, Phorbol ester induced phosphorylation of dopamine transporters in rat striatum, Soc. Neurosci. Abstr. 22 (1996) 509.
43. [43] R.A. Vaughan, M.J. Kuhar, Dopamine transporter ligand binding domains. Structural and functional properties revealed by limited proteolysis, J. Biol. Chem. 271 (1996) 21672-21680.
44. 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration, J. Neurosci. 14 (1994) 2966-2979.
45. [45] R.A. Wise, Action of drugs of abuse on brain reward systems, Pharmacol. Biochem. Behav. 13 (1980) 213-223.
46. [46] M.J. Zigmond, E.D. Abercrombie, T.W. Berger, A.A. Grace, E.M. Stricker, Compensations after lesions of central dopaminergic neurons: some clinical and basic implications, Trends Neurosci. 13 (1990) 290-296.